Taiwan’s biotech industry is expanding steadily, supported by strong government commitment and private sector interest. A 2009 national plan for biotechnology development helped kick-start the domestic market, which almost doubled in size over the next five years. Over the years, Taiwan has created a favorable environment for its biotechnology and pharmaceutical industries, which encompass the applied biotechnology, pharmaceutical and medical device sectors. Already in place is a highly-regarded clinical research infrastructure, a high-quality, low-cost research and development (R&D) and manufacturing environment, a large talent pool with capabilities in both fundamental and applied research as well as product development, and an industry culture that respects intellectual property rights.
- With its National Health Insurance program covering almost all of its 23 million citizens, Taiwan has one of the world’s best healthcare systems, renowned for its efficiency and patient outcomes. Remarkably all this is achieved through a mere 6.25% GDP spend.
- Taiwan has exceptional clinical trial capabilities and infrastructure and is considered a global leader in both compliance, speed and safety. A reflection of this is Taiwan being the first in the world to approve Afatinib for first-line treatment of EGFR mutation-positive non-small cell lung cancer (NSCLC), a result of the rapid completion of local clinical trials.
Taiwan Bio Industry Association
Since its founding in 1989, the Taiwan Bio Industry Organization (TBIO) has worked closely with industry, government departments and academia to promote biotechnology and its contribution to Taiwan’s economy and the health of its people. The more than 100 organizations and 3,000 individuals that make up TBIO membership represent the entire life sciences industry spectrum, including from the biotechnology, pharmaceutical, diagnostics, medical devices and materials, agricultural biotechnology, and nutraceuticals sectors.
Taiwan BIO Introduction
This one-pager gives an overview of Taiwan Bio Industry Association’s activities.See Publication